Capha Pharmaceuticals Inc.
$0.00+0.00%(+$0.00)
TickerSpark Score
37/100
100
Valuation
20
Profitability
15
Growth
20
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FPSUF research report →
52-Week Range100% of range
Low $0.00
Current $0.00
High $0.00
Company
Capha Pharmaceuticals Inc. does not have significant operations. It intends to explore opportunities in the pharmaceutical distribution business.
- CEO
- James R. Brown
- IPO
- 2009
- HQ
- West Kelowna, BC, CA
Price Chart
-0.00% · this period
Valuation
- Market Cap
- $6.44K
- P/E
- -0.21
- P/S
- 0.00
- P/B
- -0.01
- EV/EBITDA
- -13.93
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 7.43%
- ROIC
- 931.45%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-70,773 · -32.63%
- EPS
- $-0.00 · -37.50%
- Op Income
- $-50,745
- FCF YoY
- 3.19%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 2.53
- Avg Volume
- 142
Get TickerSpark's AI analysis on FPSUF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our FPSUF Coverage
We haven't published any research on FPSUF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate FPSUF Report →Similar Companies
ACCA+0.00%
Acacia Diversified Holdings, Inc.
$0.00
CRXM+9900.00%
Gene Biotherapeutics, Inc.
$0.00
EQUR-99.50%
E-Qure Corp.
$0.00
GLSHQ+0.00%
Gelesis Holdings, Inc.
$0.00
HBOSF+0.00%
EastWest Bioscience Inc.
$0.00
ABMC+0.00%
American Bio Medica Corporation
$0.00
TAUG+0.00%
Tauriga Sciences, Inc.
$0.00
INTP+0.00%
Integrated Pharmaceuticals, Inc.
$0.00